Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 2
2014 1
2015 2
2016 2
2017 6
2018 7
2019 5
2020 6
2021 14
2022 14
2023 12
2024 9
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
[Invasive pulmonary aspergillosis].
Blanchard E, Gabriel F, Jeanne-Leroyer C, Servant V, Dumas PY. Blanchard E, et al. Among authors: dumas py. Rev Mal Respir. 2018 Feb;35(2):171-187. doi: 10.1016/j.rmr.2018.01.002. Epub 2018 Feb 23. Rev Mal Respir. 2018. PMID: 29478757 Review. French.
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
Hunault M, Pautas C, Bertoli S, Dumas PY, Raffoux E, Hospital MA, Marchand T, Heiblig M, Chantepie S, Carré M, Peterlin P, Gallego-Hernanz MP, Lemasle E, Guièze R, Simand C, Turlure P, Huynh A, Leguay T, Devillier R, Quoc SN, Duployez N, Luquet I, Penther D, Celli-Lebras K, Mineur A, Raus N, Gardin C, Socié G, Cahn JY, Ifrah N, Vey N, de Latour RP, Delabesse E, Preudhomme C, Hamel JF, Pigneux A, Récher C, Dombret H. Hunault M, et al. Among authors: dumas py. NEJM Evid. 2025 Jul;4(7):EVIDoa2400326. doi: 10.1056/EVIDoa2400326. Epub 2025 Jun 24. NEJM Evid. 2025. PMID: 40552969 Clinical Trial.
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia.
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Crinier A, et al. Among authors: dumas py. Cell Mol Immunol. 2021 May;18(5):1290-1304. doi: 10.1038/s41423-020-00574-8. Epub 2020 Nov 25. Cell Mol Immunol. 2021. PMID: 33239726 Free PMC article.
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.
Dumas PY, Raffoux E, Bérard E, Bertoli S, Hospital MA, Heiblig M, Desbrosses Y, Bonmati C, Pautas C, Lambert J, Orvain C, Banos A, Pasquier F, Peterlin P, Marchand T, Uzunov M, Frayfer J, Turlure P, Cluzeau T, Jourdan E, Himberlin C, Tavernier E, Villate A, Haiat S, Chretien ML, Carre M, Chantepie S, Vaida I, Wemeau M, Chebrek S, Guillerm G, Guièze R, Debarri H, Gehlkopf E, Laribi K, Marcais A, Santagostino A, Béné MC, Mineur A, Pigneux A, Dombret H, Récher C. Dumas PY, et al. Leukemia. 2023 Jan;37(1):91-101. doi: 10.1038/s41375-022-01742-7. Epub 2022 Nov 14. Leukemia. 2023. PMID: 36376378 Free article.
Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study.
Petit C, Higue J, Acheaibi Z, Gilhodes J, Hospital MA, Devillier R, Bewersdorf J, Goldberg AD, Pigneux A, Vey N, Récher C, Stahl M, Bertoli S, Dumas PY, Garciaz S. Petit C, et al. Among authors: dumas py. Am J Hematol. 2025 May;100(5):906-908. doi: 10.1002/ajh.27626. Epub 2025 Mar 15. Am J Hematol. 2025. PMID: 40088036 No abstract available.
AML consolidation therapy: timing matters.
Reimann AM, Schalk E, Jost F, Mougiakakos D, Weber D, Döhner H, Récher C, Dumas PY, Ditzhaus M, Fischer T, Sager S. Reimann AM, et al. Among authors: dumas py. J Cancer Res Clin Oncol. 2023 Nov;149(15):13811-13821. doi: 10.1007/s00432-023-05115-0. Epub 2023 Aug 3. J Cancer Res Clin Oncol. 2023. PMID: 37535164 Free PMC article.
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.
Fandrei D, Pegliasco J, Pasquier F, Ibrahim N, Kfoury M, Berthon C, Heiblig M, Lebon D, Marçais A, Meunier M, Al Jijakli A, Lemasle E, Chantepie S, Pautas C, Dumas PY, Salanoubat C, Carp D, Loyaux R, Quivoron C, Pages A, Job B, Jelin R, Jules-Clement G, Antony-Debré I, Renneville A, Cotteret S, Itzykson R, Dombret H, Duployez N, Droin N, Leary A, Marzac C, Bernard E, Micol JB. Fandrei D, et al. Among authors: dumas py. Clin Cancer Res. 2025 Jun 3;31(11):2241-2253. doi: 10.1158/1078-0432.CCR-24-3683. Clin Cancer Res. 2025. PMID: 40162927
[Management of AML in the elderly].
Dumas PY, Pigneux A. Dumas PY, et al. Bull Cancer. 2023 Apr;110(4):424-432. doi: 10.1016/j.bulcan.2023.02.005. Epub 2023 Mar 2. Bull Cancer. 2023. PMID: 36870810 Review. French.
86 results